The Importance of Recognizing Cannabinoid Hyperemesis Syndrome from Synthetic Marijuana Use
- PMID: 28353201
- PMCID: PMC5440325
- DOI: 10.1007/s13181-017-0612-x
The Importance of Recognizing Cannabinoid Hyperemesis Syndrome from Synthetic Marijuana Use
Conflict of interest statement
Conflicts of Interest
None.
Sources of Funding
None.
Comment in
-
In Reply: "The importance of recognizing cannabinoid hyperemesis syndrome from synthetic marijuana use".J Med Toxicol. 2017 Jun;13(2):201. doi: 10.1007/s13181-017-0613-9. Epub 2017 Apr 5. J Med Toxicol. 2017. PMID: 28382464 Free PMC article. No abstract available.
Comment on
-
Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.J Med Toxicol. 2017 Mar;13(1):71-87. doi: 10.1007/s13181-016-0595-z. Epub 2016 Dec 20. J Med Toxicol. 2017. PMID: 28000146 Free PMC article.
References
-
- Guyatt GH, Oxman AD, Kunz R, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–926. doi: 10.1136/bmj.39489.470347.AD. - DOI - PMC - PubMed
-
- Odgen DW. Memorandum for selected United States attorneys on investigations and prosecutions in states authorizing the medical use of marijuana. Department of Justice. 2009. https://www.justice.gov/opa/blog/memorandem-selected-united-state-attorn.... Accessed 03 March, 2017.
-
- Healthcare cost and utilization project. National inpatient sample. Agency of Healthcare Research and Quality; Rockville. Accessed 03 March, 2017.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical